Rucker Michael A. 4

What Happened Michael A. Rucker, a director of Pediatrix Medical Group, was granted 7,196 restricted shares on May 7, 2026. The award was granted at $0.00 per share (an equity grant, not a purchase), so no cash was paid on acquisition.

Key Details

• Transaction date: 2026-05-07; Form 4 filed: 2026-05-11 (filed within the SEC two-business-day deadline).
• Transaction type/code: Award/Grant (A).
• Shares received: 7,196 restricted shares; acquisition price reported as $0.00.
• Vesting: Shares will vest on May 7, 2027 (per filing footnote under the 2008 Incentive Compensation Plan).
• Shares owned after transaction: Not specified in the provided excerpt.
• Not a 10% owner transaction; no sale or exercise reported.

Context This was an annual equity award under the issuer’s Amended and Restated 2008 Incentive Compensation Plan. Restricted-share grants are a common form of director compensation; they represent future equity subject to vesting and are not the same as an open-market purchase or sale.